United Therapeutics (UTHR) Misses Q2 Earnings Estimates

United Therapeutics (UTHR) came out with quarterly earnings of $5.85 per share, missing the Zacks Consensus Estimate of $6.33 per share. This compares to earnings of $5.24 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of -7.58%. A quarter ago, it was expected that this drugmaker would post earnings of $5.63 per share when it actually produced earnings of $6.17, delivering a surprise of 9.59%. Over the last four quarters, the c ...